Inj, remdesivir, 1 mg
Products billed under this code include Veklury.
Payment limit per 1 MG, by effective quarter, 4Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Veklury.
Payment limit per 1 MG, by effective quarter, 4Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Veklury | Gilead Sciences, Inc. | 61958-2901-02 | 100 | $751.10 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $7.511 | $0.00 | 1 MG | Inj, remdesivir, 1 mg | v1, posted September 17, 2026 |
| 3Q26 | $7.511 | +$0.613 | 1 MG | Inj, remdesivir, 1 mg | v1, posted September 15, 2026 |
| 2Q26 | $6.898 | $0.00 | 1 MG | Inj, remdesivir, 1 mg | v1, posted September 15, 2026 |
| 1Q26 | $6.898 | +$0.169 | 1 MG | Inj, remdesivir, 1 mg | v1, posted September 15, 2026 |
| 4Q25 | $6.729 | $0.00 | 1 MG | Inj, remdesivir, 1 mg | v1, posted September 8, 2026 |
| 3Q25 | $6.729 | +$0.375 | 1 MG | Inj, remdesivir, 1 mg | v1, posted March 10, 2026 |
| 2Q25 | $6.354 | $0.00 | 1 MG | Inj, remdesivir, 1 mg | v1, posted March 10, 2026 |
| 1Q25 | $6.354 | $0.00 | 1 MG | Inj, remdesivir, 1 mg | v1, posted December 19, 2025 |
| 4Q24 | $6.354 | $0.00 | 1 MG | Inj, remdesivir, 1 mg | v1, posted June 11, 2025 |
| 3Q24 | $6.354 | +$0.296 | 1 MG | Inj, remdesivir, 1 mg | v1, posted June 11, 2025 |
| 2Q24 | $6.058 | $0.00 | 1 MG | Inj, remdesivir, 1 mg | v1, posted March 11, 2025 |
| 1Q24 | $6.058 | $0.00 | 1 MG | Inj, remdesivir, 1 mg | v1, posted December 19, 2024 |
| 4Q23 | $6.058 | $0.00 | 1 MG | Inj, remdesivir, 1 mg | v1, posted October 10, 2024 |
| 3Q23 | $6.058 | +$0.546 | 1 MG | Inj, remdesivir, 1 mg | v1, posted June 5, 2024 |
| 2Q23 | $5.512 | +$0.004 | 1 MG | Inj, remdesivir, 1 mg | v1, posted February 23, 2024 |
| 1Q23 | $5.508 | −$0.004 | 1 MG | Inj, remdesivir, 1 mg | v1, posted December 6, 2023 |
| 4Q22 | $5.512 | $0.00 | 1 MG | Inj, remdesivir, 1 mg | v1, posted June 22, 2023 |
| 3Q22 | $5.512 | $0.00 | 1 MG | Inj, remdesivir, 1 mg | v1, posted June 9, 2023 |
| 2Q22 | $5.512 | $0.00 | 1 MG | Inj, remdesivir, 1 mg | v1, posted December 14, 2022 |
| 1Q22 | $5.512 | $0.00 | 1 MG | Inj, remdesivir, 1 mg | v1, posted June 8, 2022 |
| 4Q21 | $5.512 | – | 1 MG | Inj, remdesivir, 1 mg | v1, posted June 2, 2022 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.